发明名称 CINNOLINE DERIVATIVES USEFUL AS CB-1 RECEPTOR INVERSE AGONISTS
摘要 The present invention is directed to cinnoline derivatives pharmaceutical compositions containing them and their use in the treatment of disorders and conditions mediated by the CB-1 receptor; more particularly, use in the treatment of disorders and conditions responsive to inverse agonism of the CB-1 receptor. More particularly, the compounds of the present invention are useful in the treatment of metabolic disorders.
申请公布号 US2016200719(A1) 申请公布日期 2016.07.14
申请号 US201614992464 申请日期 2016.01.11
申请人 Janssen Pharmaceutica NV 发明人 Macielag Mark Joseph;Zhang Yue-Mei;DeCorte Bart L.;Greco Michael N.;Ludovici Donald W.;Parker Michael H.
分类号 C07D417/14;C07D403/12;C07D237/28;C07D401/12;C07D409/14 主分类号 C07D417/14
代理机构 代理人
主权项 1. A compound of formula (I) wherein R1 is selected from the group consisting of hydrogen and hydroxy;is selected from the group consisting of phenyl, furyl, thienyl, thiazolyl, benzothiazolyl and benzo[d][1,3]dioxolyl; wherein the phenyl, furyl, thienyl, thiazolyl, benzothiazolyl or benzo[d][1,3]dioxolyl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, hydroxy, C1-4alkyl, fluorinated C1-4alkyl, C1-4alkoxy, fluorinated C1-4alkoxy, cyano, —C(O)OH, C(O)O—C1-4alkyl and NRARB; wherein RA and RB are each independently selected from the group consisting of hydrogen and C1-4alkyl; provided that each substituent is bound to a carbon atom of the ring;is selected from the group consisting of phenyl, furyl, thienyl, thiazolyl, benzothiazolyl and benzo[d][1,3]dioxolyl; wherein the phenyl, furyl, thienyl, thiazolyl, benzothiazolyl or benzo[d][1,3]dioxolyl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, hydroxy, C1-4alkyl, fluorinated C1-4alkyl, C1-4alkoxy, fluorinated C1-4alkoxy, cyano, —C(O)OH, C(O)O—C1-4alkyl and NRCRD; wherein RC and RD are each independently selected from the group consisting of hydrogen and C1-4alkyl; provided that each substituent is bound to a carbon atom of the ring; a is an integer from 0 to 1; L1 is selected from the group consisting of —N(R2)—, —N(R2)—CH2— and —N(R2)—CH2CH2—; wherein R2 is selected from the group consisting of hydrogen and C1-2alkyl; and wherein the L1 is bound to the cinnoline core through a nitrogen atom;is selected from the group consisting of(wherein X is selected from the group consisting of C and N); provided that whenis selected from the group consisting ofthen a is 0 or a is 1 and L1 is other than —N(R2) and —N(R2)—CH2—; wherein R3 is selected from the group consisting of hydrogen, halogen, hydroxy, cyano, C1-4alkyl, halogenated C1-4alkyl, hydroxy substituted C1-4alkyl, C1-4alkoxy, halogenated C1-4alkoxy, —CO2H, —C(O)O—(C1-4alkyl), —(C1-4alkyl)-CO2H, —(C1-4alkyl)-C(O)O—(C1-4alkyl), —SO2—(C1-4alkyl) and —SO2-(halogenated C1-4alkyl); c is an integer from 0 to 2; each R4 is independently selected from the group consisting of halogen, C1-4alkyl, halogenated C1-2alkyl, C1-4alkoxy and halogenated C1-2alkoxy; wherein R5 is selected from the group consisting of —C(O)—(C1-4alkyl), —C(O)O—(C1-4alkyl), —SO2—(C1-4alkyl) and —SO2-(halogenated C1-4alkyl); and wherein R6 is selected from the group consisting of C1-4alkyl, halogenated C1-4alkyl, —C(O)—NRE1RF, —NRE—C(O)—(C1-4alkyl), —NRE—SO2—(C1-4alkyl), andwherein RE and RF are each independently selected from the group consisting of hydrogen, methyl and ethyl; b is an integer from 0 to 1; L2 is selected from the group consisting of —CH2—, —CH2CH2—, —NH—, —N(CH3)—, —C(O)— and —SO2—; provided that whenis selected from the group consisting ofthen b is 0 or b is 1 and L2 is other than —NH— or —N(CH3)—;is selected from the group consisting of phenyl, furan-2-yl, thien-2-yl; wherein the phenyl is optionally substituted with a substituent selected from the group consisting of halogen, hydroxy, cyano, C1-4alkyl, halogenated C1-4alkyl, hydroxy substituted C1-4alkyl, C1-4alkoxy, halogenated C1-4alkoxy, —CO2H, —C(O)O—(C1-4alkyl), —(C1-4alkyl)-CO2H, —(C1-4alkyl)-C(O)O—(C1-4alkyl), —SO2—(C1-4alkyl) and —SO2-(halogenated C1-4alkyl); and wherein the phenyl is further optionally substituted with one to two additional substituents independently selected from the group consisting of halogen, C1-4alkyl, halogenated C1-2alkyl, C1-4alkoxy and halogenated C1-2alkoxy; and wherein the furan-2-yl or thien-2-yl is optionally substituted with a substituent selected from the group consisting of halogen, C1-4alkyl, halogenated C1-4alkyl, C1-4alkoxy, halogenated C1-4alkoxy, —CO2H, —C(O)O—(C1-4alkyl) and —C(O)—NRGRH; wherein RG and RH are each independently selected from the group consisting of hydrogen, methyl and ethyl; or a stereoisomer, tautomer or pharmaceutically acceptable salt thereof.
地址 Beerse BE